Geron | GERN - Actif À Court Terme





Actif À Court Terme Changement Date
Amgen USD 34.96B 3.49B 2026-06
Bio Techne USD 688.05M 50.62M 2026-03
Cassava Sciences USD 87.96M 9.74M 2026-03
Cytokinetics USD 1.21B 369.02M 2026-06
Exelixis USD 1.25B 42.18M 2026-06
Genmab DKK 2.8B 228M 2026-06
Geron USD 486.34M 12.19M 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
Incyte USD 6.03B 542.31M 2026-06
MacroGenics USD 182.52M 37.42M 2026-03
Novartis USD 27.35B 744M 2026-06
Novavax USD 771.1M 79.72M 2026-06